MiNDERA Corporation: Funding, Investors & Team (Sep 2026)
MiNDERA Dx conducts innovative work on harmless atomic testing for skin malignant growth and other skin infections. The organization is right now centered around an innovation answer for separate skin biomarkers in a harmless way. It was established in 2013 and is situated in San Francisco, United States.
MiNDERA Corporation has raised $14.1M across 2 funding rounds on record, the most recent a Debt Financing of $2.1M announced in Jun 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MiNDERA Corporation Company Profile and Key Stats
Latest funding round on record: Jun 2022.
MiNDERA Corporation Funding Rounds
MiNDERA Corporation raised $12.0M in an undisclosed round announced in May 2021.
1.1 years later, a Debt Financing of $2.1M was announced in Jun 2022.
MiNDERA Corporation Founders and Leadership Team
Contact details for the MiNDERA Corporation team: 2 of 2 have an email address on file.
Start 14-day free trial →MiNDERA Corporation Funding Compared to Other Biotechnology Startups
MiNDERA Corporation's latest round of $2.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MiNDERA Corporation in Biotechnology and South San Francisco
Companies Similar to MiNDERA Corporation
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
MiNDERA Corporation Funding FAQs
What does MiNDERA Corporation do?
MiNDERA Dx conducts innovative work on harmless atomic testing for skin malignant growth and other skin infections. The organization is right now centered around an innovation answer for separate skin biomarkers in a harmless way. It was established in 2013 and is situated in San Francisco, United States.
How much funding has MiNDERA Corporation raised?
MiNDERA Corporation has raised $14.1M across 2 rounds on record. The most recent is a Debt Financing of $2.1M announced in Jun 2022.
When did MiNDERA Corporation last raise funding?
MiNDERA Corporation's most recent funding round on record is a Debt Financing of $2.1M, announced in Jun 2022.
Who founded MiNDERA Corporation?
FundedIQ lists Tobin Dickerson (Founder) at MiNDERA Corporation.
Who is the CEO of MiNDERA Corporation?
George Mahaffey is listed as CEO at MiNDERA Corporation.
Where is MiNDERA Corporation headquartered?
MiNDERA Corporation is based in South San Francisco, California, United States.
How many employees does MiNDERA Corporation have?
MiNDERA Corporation is in the 11-50 employee band.
How does MiNDERA Corporation's funding compare to other Biotechnology startups?
MiNDERA Corporation's latest round of $2.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's MiNDERA Corporation Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MiNDERA Corporation is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.